Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Buys Biochemicals Firm Research Organics

NEW YORK (GenomeWeb News) – Sigma-Aldrich announced after the close of the market on Monday that it has acquired high purity biochemicals firm Research Organics for an undisclosed amount.

Founded in 1953 and based in Cleveland, Research Organics supplies biochemicals for use in molecular biology, diagnostics, cell culture, pharmaceuticals, biopharmaceuticals, life sciences, and biotechnology. Its portfolio includes biological buffers, molecular biology grade products, reagent biochemicals, and other products.

The deal, Sigma-Aldrich said, is expected to expand that firm's buffer production capacity and increase the size of its portfolio of PharmaGrade raw materials for the diagnostics and biopharmaceuticals markets.

Research Organics will be folded into SAFC, the custom manufacturing and services business unit of Sigma-Aldrich, which said the deal is anticipated to be neutral to earnings per share in 2012.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.